BIMI Holdings Inc. (BIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Dec 5, 2025
BIMI Holdings Revenue
BIMI Holdings had revenue of $2.52M in the quarter ending September 30, 2023, a decrease of -48.85%. This brings the company's revenue in the last twelve months to $12.63M, up 91.60% year-over-year. In the year 2022, BIMI Holdings had annual revenue of $11.83M, down -44.51%.
Revenue (ttm)
12.63M
Revenue Growth
+91.60%
P/S Ratio
0.00
Revenue / Employee
42.68K
Employees
296
Market Cap
1.40K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
BIMI Holdings News
- 1 year ago - BIMI Pharmaceuticals (BIMI) Stock Plummets 72% in OTC Market - GuruFocus
- 1 year ago - BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq - GlobeNewsWire
- 2 years ago - BIMI Announces Results of 2023 Annual General Meeting of Stockholders - GlobeNewsWire
- 2 years ago - BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results - GlobeNewsWire
- 2 years ago - BIMI Announces Buyback of Warrants - GlobeNewsWire
- 2 years ago - BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results - GlobeNewsWire
- 2 years ago - BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 2 years ago - BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch - GlobeNewsWire